Connect with us

News

Why the #empowHER50 Campaign is a Call to Action to Democratize AI for All

Published

on

By Chaitra Vedullapalli, Co-Founder, Women in Cloud

As Microsoft marks its 50th anniversary—celebrating five decades of innovation, leadership, and global impact—it’s a powerful moment to honor the people who helped shape the digital economy. Behind Microsoft’s trillion-dollar market shift are not only visionary founders and technologists, but also women whose contributions boldly transformed the world.

For over five decades, women at Microsoft—past and present—have been pioneers, expanding access, scaling innovation, and redefining what’s possible. Leaders like Nathalie D’Hers, Jacky Wright, Amy Hood, Sumit Chauhan, Joy Chik, Gavriella Schuster, Julia White, Dawn Trudeau, Trish Millines Dziko, and Kate Behncken embody the spirit of resilience, inclusion, and purpose that powers Microsoft’s enduring impact.

As we step into the next era of transformation, we rise as a united global force to democratize access, inspire future generations, and prepare women to lead in AI and next-generation technologies. Our collective legacy is a call to action to build a more inclusive, empowered, and prosperous digital economy for all.

That’s why today, with heartfelt gratitude, the Women in Cloud ecosystem is turning the spotlight on these extraordinary women. Through our #empowHER50 campaign, we proudly honor over fifty exceptional leaders who have helped power Microsoft’s trillion-dollar market shift and built the digital infrastructure driving today’s global economy. These women have democratized access to technology, created economic opportunities, and opened doors for millions. Today, we celebrate their impact, amplify their stories, and express our deepest appreciation for shaping a more inclusive and empowered future for all.

Their stories show that when women lead in tech, everyone gains.

Four Stories That Will Change How You See the Future

Here are powerful stories from the #empowHER50 honorees that will move you—and show how women have been instrumental in powering Microsoft’s trillion-dollar shift and democratizing computing access.

Yanna Andronopoulou: Building AI Access Across Europe

In Southeast Europe, Yanna Andronopoulou has been quietly leading a movement to bridge the digital divide. As Microsoft’s General Manager for Greece, Cyprus, Malta, and sponsor of Women Employee Resource Group (ERG), she launched the Women’s AI Hackathon across nine countries, attracting over 900 applicants and equipping 100 women with AI skills to shape the digital future in their communities. Her leadership extended beyond events—Yanna drove Greece’s largest AI skills program, AI School 360, ensuring 50% female participation, and partnered with local organizations to upskill 4,000+ women with digital literacy and career opportunities. Her work earned Microsoft Greece the Inclusivity Award and recognition as an international advocate for equity in tech.

“Together, we can ignite change and shape a future where women not only thrive but lead in technology,” Yanna reminds us.”

Gavriella Schuster: Architecting Allyship and Access

Gavriella Schuster is a force behind the structural shifts that expanded access for women in technology. As a Corporate Vice President at Microsoft, she not only transformed the company’s partner ecosystem but also became a global advocate for inclusion. Gavriella sponsored the creation of The WIT Network, now spanning 11,000+ members across 76 countries, providing mentorship and technical certifications to women in tech. She co-founded Women in Cloud, helping over 120,000 women access economic opportunities and cloud marketplaces.

Beyond corporate leadership, Gavriella has personally mentored over 100 women, launched mentorship rings, and delivered a TEDx talk calling for 8 million women to enter tech. She developed allyship training programs now used by Fortune 500 leaders to create inclusive cultures.

If a person who is an ONLY in any group has an ally, they are not alone, #ALLIES step up in the moments that matter through the little acts they practice every day to turn moments of exclusion into moments of inclusion. ” Gavriella says—a message that has fueled a global movement.

Jenny Lay-Flurrie: Making Technology Accessible for 1.3 Billion People

Jenny Lay-Flurrie’s story is a masterclass in how technology can be truly inclusive. As Microsoft’s Chief Accessibility Officer (CAO), Jenny leads one of the world’s most comprehensive accessibility initiatives, designed to empower the 1.3 billion people with disabilities worldwide.

Accessibility at Microsoft began in 1995 with Windows 95, but under Jenny’s leadership since 2016, it became an all-company movement. She helped embed accessibility training into the culture, reaching over 5 million people globally, ensuring every Microsoft employee knows how to create inclusive experiences.

From launching products like Read Aloud, Immersive Reader, Windows Captions, and Eye Control—used by millions monthly—to pioneering innovations like the Xbox Adaptive Controller, Jenny and her team have made it clear that accessible technology benefits everyone. She also championed hiring initiatives such as the Neurodiversity Hiring Program and led Microsoft’s Ability Summit, which grew from 20 attendees to over 20,000 participants in 2025.

“Accessibility makes technology easier for everyone,” Jenny says. Her work is proof that inclusive design isn’t optional; it’s essential.”

Melissa Mulholland: Turning Personal Adversity Into Industry Impact

For Melissa Mulholland, technology and impact are inseparable. While at Microsoft, she confronted a life-altering moment when her unborn son was diagnosed with a rare and life-threatening condition. That experience reshaped her perspective on how AI could be used to improve healthcare outcomes.

As Director of Business Strategy at Microsoft, she began advocating for the responsible use of AI in patient care. Today, as CEO of Crayon, she leads efforts to apply AI in healthcare at scale, including partnerships with Oslo University Hospital to enhance cancer screening and real-time patient monitoring.

Mulholland’s story illustrates how personal experience can sharpen a leader’s vision—and how technology, when grounded in purpose, can drive lasting change.

The Power of Collective: Women in Cloud’s Impact

The #empowHER50 campaign is part of a broader movement to democratize economic access for women in technology. At Women in Cloud, we have built a global platform to remove barriers and create pathways to opportunity. Over the past five years:

  1. Generated $500M+ in economic impact, supporting 120,000+ members worldwide.
  2. Empowered 5,000+ women in 80+ countries with Microsoft AI and cybersecurity certifications, accelerating their careers in DevSecOps.
  3. Engaged 4 million+ individuals globally through 300+ events and 32 industry partnerships, including setting a Guinness World Record for the largest vision board video hangout.
  4. Launched the empowHERaccess Prestige Awards, recognizing 2,500+ women, allies, and organizations driving inclusive innovation.
  5. Received formal recognition through Washington Senate Resolution 8621, honoring Women in Cloud’s role in inspiring women and girls in technology.

We believe that access to technology is access to opportunity, and when we invest in women, we invest in the future.

A Historic Celebration: Honoring the Women Who Powered Microsoft’s Trillion-Dollar Shift

As Microsoft marks its 50th anniversary, it’s time to recognize the women whose innovation, leadership, and vision helped shape the digital economy. The #empowHER50 campaign highlights those who expanded access, built critical infrastructure, and helped drive Microsoft’s trillion-dollar market shift—women who changed the trajectory of technology for billions.

Their contributions underscore a clear truth: inclusion is not optional—it’s a competitive advantage. The next trillion-dollar shift in tech will be defined by who builds it.

Join us on July 18, 2025, at the empowHERaccess Awards and Recognition Gala to celebrate the women who helped shape Microsoft and the global tech industry—and connect with those building what’s next.

Reserve your seat today.

Their stories shaped our present. Your presence will shape the future.

Fertility

Housing, work and fertility stop Britons having the families they want – research

Published

on

Housing, work and fertility pressures are stopping many Britons growing the families they want, new research suggests.

A UK fertility report found that 79 per cent of people surveyed who had tried to conceive in the past five years would like more children than they currently have.

Among parents with one child, that figure rises to 88 per cent.

The report surveyed more than 1,000 people across the UK who had tried for a baby in the past five years.

While birth rates continue to fall, the findings suggest it is not because people no longer want children. Instead, many respondents said external pressures are making it harder to grow their families.

The findings, from wellness brand Wild Nutrition’s Fertility Disconnect report, highlight how financial pressures, fertility struggles and gaps in reproductive health knowledge are shaping modern family life in the UK.

Gail Madalena, fertility nutritional therapist at Wild Nutrition, said: “People often assume fertility begins the moment they decide to try [for a baby].

“In reality, egg and sperm health are shaped months and years earlier.

“By the time someone starts thinking about fertility, their body has already been responding to its environment for a long time.”

Among the biggest barriers, 26 per cent said career progression affected their family plans, 25 per cent cited housing affordability and lack of space, and 52 per cent said they required medical intervention during their fertility journey.

The report also found that almost a quarter of respondents had spent more than two years trying to conceive.

Trying for a baby can take a significant toll on mental health and relationships, especially for those navigating fertility treatment.

According to the research, 38 per cent of respondents said trying to conceive had negatively affected their mental health. That figure rose to 99 per cent among people undergoing fertility treatment.

Julianne Boutaleb is a perinatal psychologist.

She said: “Navigating a fertility journey is about so much more than medical appointments and procedures.

“It’s an emotional marathon that can take a huge toll on your mental wellbeing.

“Sadly, the stats show that 15 per cent of couples going through fertility treatment say their relationship has been irrevocably impaired.”

The report also highlighted the realities of secondary infertility, which affects around one in 20 people, challenging the assumption that having one child means conceiving again will be straightforward.

Researchers found many people felt under-informed about fertility, particularly younger adults.

Ten per cent of Gen Z respondents said they “know nothing” about fertility, while only one in five respondents said they know “a lot” about egg health.

The report also found that 60 per cent of women were unaware of fertility testing options, and one in five Gen Z respondents said they felt uncomfortable discussing fertility, even with their partner.

Around 40 per cent of those surveyed supported fertility education being included in schools, covering topics such as egg health, sperm health and hormonal health.

The report also explored how lifestyle and long-term health may influence fertility outcomes.

Many respondents said they only made changes once they started trying to conceive.

Some 44 per cent improved their diet when trying for a baby, while 32 per cent reduced alcohol intake at that stage.

The report also referenced emerging research that suggests ultra-processed foods and microplastics could have an impact on reproductive health.

While fertility conversations often focus on women, the findings showed male fertility issues are also affecting many families.

Seventeen per cent of respondents cited sperm health issues as a barrier to conception, while male factors contribute to around half of all fertility challenges.

Only one in four men said they would share fertility struggles with friends.

“Many causes of male infertility are entirely treatable yet so often the last resort is the first response,” said Ian Stones, co-founder at Test Him Ltd.

The findings come as UK birth rates remain below replacement level.

The report noted that the UK fertility rate is now 1.41, meaning that on average women give birth to 1.41 children over their lifetimes. The replacement rate, or rate that maintains population numbers, is 2.1.

It also said the average age of mothers has risen to 31, while birth rates are falling across most age groups except among over-40s.

“There is no single fertility story, and it is rarely a simple, linear narrative,” said Dr Zeynep Gurtin, lecturer in women’s health at UCL.

Dr Gurtin added that better fertility education, fairer access to treatment and more open conversations around infertility and pregnancy loss are needed.

Continue Reading

Fertility

Femtech World reveals fertility innovation award shortlist

Published

on

Femtech World is thrilled to reveal the shortlist for the Fertility Innovation Award.

The award, sponsored by FinDBest IVF, celebrates a pioneering product, service or initiative that is transforming fertility care and support.

FinDBest IVF is a global B2B digital platform created to simplify and accelerate how IVF and ART manufacturers connect with trusted, pre-vetted distributors around the world.

This year’s nominees represent a remarkable breadth of approaches to fertility care: from clinic-floor breakthroughs to at-home hormone intelligence to truly borderless access.

Three companies made the cut, with each tackling a real, persistent barrier in reproductive health.

Congratulations to the shortlist and many thanks to everyone who entered.

Fertility Innovation Award Shortlist

 

HRC Fertility’s Needle-Free IVF is a pioneering advancement designed to transform one of the most challenging aspects of fertility treatment: daily hormone injections.

Developed by board-certified reproductive endocrinologist Dr Rachel Mandelbaum, this innovative approach reimagines how stimulation medications are delivered during IVF and egg freezing, dramatically improving the patient experience while maintaining the same trusted clinical outcomes.

Inspired by feedback from patients who struggled with the injection process, Dr Mandelbaum adapted an innovative drug-delivery system commonly used in other areas of medicine and applied it to reproductive care

Mira is a hormonal health technology company that provides lab-grade hormone testing and AI-driven insights to help women and couples understand their fertility. 

The platform has already supported more than 200,000 couples on their fertility journeys worldwide, helping over 60,000+ users achieve pregnancy.

For some users, pregnancy rates have reached up to 89 per cent within six months, demonstrating how accurate hormone data can significantly improve fertility outcomes.

 

Founded in 2021 by Marija Skujina, a Certified Fertility Nurse Specialist accredited by the European Society of Human Reproduction and Embryology, with nearly 15 years of clinical experience at one of the world’s top IVF clinics, and having navigated her own fertility journey as a patient, Marija built the clinic she had always wished existed.

Plan Your Baby began with a bold, but simple mission – make best quality fertility and pregnancy available anywhere.

Plan Your Baby has created a new generation fertility and pregnancy clinic with patients accessing expert consultations remotely, while blood tests and ultrasound scans are available at over 450 locations across the UK, eliminating the exhausting travel burden that often forces people to take days off work, relocate appointments, or abandon treatment altogether

What happens now

The shortlist will be judged by a representative from category sponsor FindBestIVF, with the winner announced at a virtual event on June 19.

Winners will receive a trophy and be interviewed by a Femtech World journalist.

Continue Reading

Cancer

Common cholesterol drug shows ovarian cancer promise

Published

on

A common cholesterol drug could help weaken a fluid shield that helps ovarian cancer tumours survive, early lab findings suggest.

The findings do not show the drug treats ovarian cancer. But they suggest changing the environment the cancer depends on could make it more vulnerable to existing treatment.

A federally funded study at Duke University School of Medicine found that ascites, a build-up of fluid in the abdomen, may do more than cause discomfort.

Doctors can drain ascites to ease pain, improve mobility and make breathing easier, but the fluid may also help cancer cells survive and spread. It occurs in 90 per cent of people with advanced ovarian cancer.

According to the study, ascites acts as a shield, helping cancer cells evade ferroptosis, a form of cell death.

Ferroptosis is a kind of cellular rusting. It happens when iron inside a cell reacts with certain fats, causing the cell membrane to break apart.

Many metastatic cancer cells, meaning cells that float freely through the abdomen looking for new places to grow, are naturally vulnerable to this kind of damage.

“Doctors have mostly viewed ascites as a symptom rather than an active driver of disease,” said Jen-Tsan Chi, professor in the department of molecular genetics and microbiology and co-leader of the Cancer Biology Program at the Duke Cancer Institute.

“We’ve learned it gives cancer a survival advantage, which fills a major gap in understanding how ovarian cancer spreads.”

Scientists bathed cancer cell lines and patient-derived tumour cells in ascites collected from patients and watched how they responded to ferroptosis triggers.

The fluid protected cancer cells by changing how they store fats and control iron levels, effectively blocking cell death.

The protection required only trace amounts, with as little as 2 per cent immersion shielding cancer cells from destruction.

“What surprised us was how selective this effect was,” said Yasaman Setayeshpour, first author and graduate student in molecular genetics and microbiology at Duke School of Medicine.

“Ascites didn’t protect the cancer cells from other well-known types of cell death, like apoptosis or necrosis, it only blocked ferroptosis.

“To figure out why, we broke ascites down into major parts, like lipids, proteins, and small molecules, and tested what happened when each was removed.

“When we took the lipids out, the protective effect disappeared. That told us lipids are the key reason ascites helps these cancer cells survive.”

But researchers found an unexpected helper in bezafibrate, an older cholesterol drug used to lower triglycerides by altering how the body processes fats.

The cholesterol drug restored sensitivity to ferroptosis, but only when ascites was present. On its own, the drug did not trigger cell death or slow tumour growth in mice.

The drug’s impact depended on the cancer’s surroundings, in this case the fat-rich fluid bathing the tumour. Researchers found that targeting this environment, using repurposed drugs like bezafibrate, could leave cancer cells more exposed to existing cancer treatments.

Chi said the finding could have implications beyond ovarian cancer. Other cancers, including colorectal and pancreatic cancers, can also spread within the abdominal cavity.

“This work shows how much the environment around a tumour matters,” Chi said.

“Biological fluids like ascites don’t just give cancer cells a place to move. They actively help drive how cancer spreads.”

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.